Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

van Beek, Nina; Kruger, Stine; Fuhrmann, Tarek; Lemcke, Susanne; Goletz, Stephanie; Probst, Christian; Komorowski, Lars; Di Zenzo, Giovanni; Dmochowski, Marian; Drenovska, Kossara; Horn, Michael; Jedlickova, Hana; Kowalewski, Cezary; Medenica, Ljiljana; Murrell, Dedee; Patsatsi, Aikaterini; Geller, Shamir; UZUN, SONER; Vassileva, Snejina; Zhu, Xuejun; Fechner, Kai; Zillikens, Detlef; Stocker, Winfried; Schmidt, Enno; Rentzsch, Kristin

doi:10.1016/j.jaad.2020.01.049

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

Atıf İçin Kopyala

van Beek N., Kruger S., Fuhrmann T., Lemcke S., Goletz S., Probst C., ...Daha Fazla

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, cilt.83, sa.5, ss.1315-1322, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 83 Sayı: 5
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.jaad.2020.01.049
Dergi Adı: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
Sayfa Sayıları: ss.1315-1322
Anahtar Kelimeler: autoimmune bullous diseases, biochip, immunofluorescence, pemphigoid, pemphigus, EUROPEAN ACADEMY, GUIDELINE
Akdeniz Üniversitesi Adresli: Evet

Özet

Background: The current standard in the serologic diagnosis of autoimmune bullous diseases (AIBD) is a multistep procedure sequentially applying different assays. In contrast, the BIOCHIP Mosaic technology combines multiple substrates for parallel analysis by indirect immunofluorescence.